GAPDH and neoplasm: In tumour infiltrating T lymphocytes, low levels of glucose trigger binding of Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) to IFNγ transcripts, this interferes with histone acetylation preventing differentiation of CD4+ T cells into the immunogenic Th1 phenotype (Chang et al., 2013).